论文部分内容阅读
目的:探讨经静脉滴注红霉素治疗急诊支气管哮喘的临床有效性分析。方法:通过选自于2016年1月至2016年12月期间在我院进行治疗的急诊支气管哮喘患者100例作为本次研究对象,按照随机抽号的方法将患者分为两组,对照组和观察组(n=50例)。对照组患者行BDP(双倍二丙酸倍氯米松)治疗,观察组患者则在对照组患者的基础之上行红霉素静脉滴注治疗,对比分析两组患者的临床治疗成效。结果:在施以不同的治疗方法之后,对照组患者的治疗有效率明显低于观察组的治疗有效率,两组存在显著差异,对照组患者与观察组患者在治疗前临床病症评分均无显著差异,在施以不同的治疗方法之后,对照组患者评分在2h、4h、6h阶段均明显低于观察组患者(P<0.05)。结论:通过对急诊支气管哮喘患者行静脉滴注红霉素药物,能够具有显著的治疗成效,并且能够在较短的时间内缓解患者的临床病症,具有临床推广意义。
Objective: To investigate the clinical efficacy of intravenous erythromycin in the treatment of acute bronchial asthma. METHODS: One hundred patients with acute bronchial asthma who were treated in our hospital from January 2016 to December 2016 were selected as the study subjects. The patients were divided into two groups according to the random drawing method. The control group and Observation group (n = 50). Patients in the control group were treated with BDP (beclomethasone dipivoxil), while patients in the observation group were treated with intravenous erythromycin intravenously on the basis of the control group. The clinical efficacy of the two groups was compared. Results: After applying different treatment methods, the treatment efficiency of the control group was significantly lower than that of the observation group, there was a significant difference between the two groups, and there was no significant difference in the clinical symptoms before and after treatment between the control group and the observation group Differences in the application of different treatment methods, the control group score 2h, 4h, 6h stage were significantly lower than the observation group patients (P <0.05). Conclusion: It is of clinical significance to inject erythromycin into patients with acute bronchial asthma by intravenous drip. It has significant therapeutic effect and can alleviate the clinical symptoms of patients in a short period of time.